US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5776429A
(en)
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
GB9216082D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Univ Nottingham |
Lymphatic delivery composition
|
US5871710A
(en)
*
|
1992-09-04 |
1999-02-16 |
The General Hospital Corporation |
Graft co-polymer adducts of platinum (II) compounds
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
GB9406094D0
(en)
*
|
1994-03-28 |
1994-05-18 |
Univ Nottingham And University |
Polymer microspheres and a method of production thereof
|
US6007845A
(en)
*
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US6040295A
(en)
*
|
1995-01-13 |
2000-03-21 |
Genemedicine, Inc. |
Formulated nucleic acid compositions and methods of administering the same for gene therapy
|
US5612052A
(en)
*
|
1995-04-13 |
1997-03-18 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US6413539B1
(en)
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
KR0180334B1
(ko)
*
|
1995-09-21 |
1999-03-20 |
김윤 |
블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
|
US5834025A
(en)
*
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
WO1997017063A1
(en)
†
|
1995-11-09 |
1997-05-15 |
Microbiological Research Authority |
Microencapsulated dna for vaccination and gene therapy
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US5985312A
(en)
*
|
1996-01-26 |
1999-11-16 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US5611344A
(en)
*
|
1996-03-05 |
1997-03-18 |
Acusphere, Inc. |
Microencapsulated fluorinated gases for use as imaging agents
|
DK0904113T3
(da)
*
|
1996-03-05 |
2004-08-30 |
Acusphere Inc |
Mikroindkapslede fluorerede gasser til anvendelse som billeddannende midler
|
WO1997040679A1
(en)
|
1996-05-01 |
1997-11-06 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US5837221A
(en)
*
|
1996-07-29 |
1998-11-17 |
Acusphere, Inc. |
Polymer-lipid microencapsulated gases for use as imaging agents
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
EP0977597B1
(de)
|
1996-09-11 |
2003-01-15 |
Imarx Pharmaceutical Corp. |
Verbesserte verfahren zur diagnostischen bilderzeugung unter verwendung eines kontrastmittels und eines vasodilators
|
WO1998018498A2
(en)
*
|
1996-10-28 |
1998-05-07 |
Marsden, John, Christopher |
Improvements in or relating to diagnostic/therapeutic agents
|
US6331289B1
(en)
|
1996-10-28 |
2001-12-18 |
Nycomed Imaging As |
Targeted diagnostic/therapeutic agents having more than one different vectors
|
US6264917B1
(en)
|
1996-10-28 |
2001-07-24 |
Nycomed Imaging As |
Targeted ultrasound contrast agents
|
US6261537B1
(en)
|
1996-10-28 |
2001-07-17 |
Nycomed Imaging As |
Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
AU739919B2
(en)
*
|
1997-04-30 |
2001-10-25 |
Point Biomedical Corporation |
Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream
|
US20020159951A1
(en)
*
|
1997-05-06 |
2002-10-31 |
Unger Evan C. |
Novel targeted compositions for diagnostic and therapeutic use
|
US20020039594A1
(en)
*
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US6275726B1
(en)
*
|
1997-05-15 |
2001-08-14 |
Board Of Regents, The University Of Texas System |
Methods of enhanced light transmission through turbid biological media
|
US6045777A
(en)
*
|
1997-06-30 |
2000-04-04 |
Acusphere, Inc. |
Method for enhancing the echogenicity and decreasing the attenuation of microencapsulated gases
|
US6165440A
(en)
*
|
1997-07-09 |
2000-12-26 |
Board Of Regents, The University Of Texas System |
Radiation and nanoparticles for enhancement of drug delivery in solid tumors
|
US6211249B1
(en)
*
|
1997-07-11 |
2001-04-03 |
Life Medical Sciences, Inc. |
Polyester polyether block copolymers
|
US6287558B1
(en)
|
1997-08-01 |
2001-09-11 |
Biohybrio Technologies Llc |
Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
|
US6548047B1
(en)
*
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
WO1999029759A1
(en)
*
|
1997-12-12 |
1999-06-17 |
Macromed, Inc. |
Heterofunctionalized star-shaped poly(ethylene glycols) for protein modification
|
US6254890B1
(en)
*
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
US6123923A
(en)
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
DE19813174A1
(de)
*
|
1998-03-25 |
1999-05-27 |
Schering Ag |
Mikropartikel aus Polymeren und mindestens einer gerüstbildenden Komponente und ihre Herstellung und Verwendung in der Ultraschalldiagnostik und zur ultraschallinduzierten Wirkstofffreisetzung
|
US20030059465A1
(en)
*
|
1998-05-11 |
2003-03-27 |
Unger Evan C. |
Stabilized nanoparticle formulations of camptotheca derivatives
|
KR19990085365A
(ko)
*
|
1998-05-16 |
1999-12-06 |
허영섭 |
지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
|
WO1999059550A1
(en)
*
|
1998-05-20 |
1999-11-25 |
The Liposome Company, Inc. |
Novel particulate formulations
|
DK1079808T3
(da)
|
1998-05-29 |
2004-06-07 |
Skyepharma Canada Inc |
Præparater med termisk beskyttede mikropartikler og fremgangsmåde til slutdampsterilisering deraf
|
GB9814507D0
(en)
*
|
1998-07-03 |
1998-09-02 |
Univ Southampton |
A method and apparatus for controlling pests
|
US7343710B2
(en)
*
|
1998-07-03 |
2008-03-18 |
I.D.A Limited |
Method and apparatus for controlling pests
|
US6179862B1
(en)
|
1998-08-14 |
2001-01-30 |
Incept Llc |
Methods and apparatus for in situ formation of hydrogels
|
DE69943297D1
(de)
*
|
1998-08-14 |
2011-05-05 |
Incept Llc |
Apparat für die in-situ-bildung von hydrogelen
|
US6632457B1
(en)
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
US6143314A
(en)
*
|
1998-10-28 |
2000-11-07 |
Atrix Laboratories, Inc. |
Controlled release liquid delivery compositions with low initial drug burst
|
AU1623300A
(en)
*
|
1998-11-13 |
2000-06-05 |
Sensor Technologies, Inc. |
Monodisperse preparations useful with implanted devices
|
EP1133281A1
(de)
|
1998-11-20 |
2001-09-19 |
RTP Pharma Inc. |
Dispergierbare mit phospholipid stabilisierte mikropartikel
|
US6365173B1
(en)
|
1999-01-14 |
2002-04-02 |
Efrat Biopolymers Ltd. |
Stereocomplex polymeric carriers for drug delivery
|
US6045826A
(en)
*
|
1999-04-02 |
2000-04-04 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
DE19921088C2
(de)
*
|
1999-04-30 |
2003-08-07 |
Magforce Applic Gmbh |
Stent zur Offenhaltung gangartiger Strukturen
|
US7829064B2
(en)
*
|
1999-05-10 |
2010-11-09 |
Immunomedics, Inc. |
Anti-CD74 immunoconjugates and methods
|
US8383081B2
(en)
*
|
1999-05-10 |
2013-02-26 |
Immunomedics, Inc. |
Anti-CD74 immunoconjugates and methods of use
|
US8119101B2
(en)
|
1999-05-10 |
2012-02-21 |
The Ohio State University |
Anti-CD74 immunoconjugates and methods of use
|
US6426145B1
(en)
|
1999-05-20 |
2002-07-30 |
Scimed Life Systems, Inc. |
Radiopaque compositions for visualization of medical devices
|
WO2000078362A2
(de)
*
|
1999-06-22 |
2000-12-28 |
Aventis Research & Technologies Gmbh & Co. Kg |
Stabile radioaktiv markierte nanopartikel, verfahren zur herstellung und ihrer verwendung
|
DE19930729A1
(de)
*
|
1999-07-05 |
2001-01-11 |
Achim Goepferich |
Blockcopolymere zur Herstellung biomimetischer Oberflächen
|
AU6636000A
(en)
*
|
1999-08-13 |
2001-03-13 |
Point Biomedical Corporation |
Hollow microspheres with controlled fragility for medical use
|
AU6635900A
(en)
*
|
1999-08-13 |
2001-03-13 |
Point Biomedical Corporation |
Microparticles useful as ultrasonic contrast agents and for lymphatic system
|
US20020041898A1
(en)
*
|
2000-01-05 |
2002-04-11 |
Unger Evan C. |
Novel targeted delivery systems for bioactive agents
|
WO2001069245A2
(en)
*
|
2000-03-14 |
2001-09-20 |
Trustees Of Tufts College |
Cross-reactive sensors
|
FR2809112B1
(fr)
*
|
2000-05-16 |
2004-05-07 |
Centre Nat Rech Scient |
Materiaux a base de polymeres biodegradables et son procede de preparation
|
EP1341497A4
(de)
*
|
2000-11-02 |
2005-10-19 |
Smithkline Beecham Corp |
Rezeptor-antagonisten-lipid-konjugate und diese enthaltende abgabeträger
|
EP2381116A1
(de)
|
2000-11-16 |
2011-10-26 |
California Institute of Technology |
Vorrichtungen und Verfahren zur Durchführung von Tests und Screening mit hohem Durchsatz
|
US6495154B1
(en)
*
|
2000-11-21 |
2002-12-17 |
Vivus Inc. |
On demand administration of clomipramine and salts thereof to treat premature ejaculation
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6869617B2
(en)
*
|
2000-12-22 |
2005-03-22 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US7193084B2
(en)
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US20020142304A1
(en)
*
|
2001-03-09 |
2002-10-03 |
Anderson Daniel G. |
Uses and methods of making microarrays of polymeric biomaterials
|
US8137699B2
(en)
*
|
2002-03-29 |
2012-03-20 |
Trustees Of Princeton University |
Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
|
KR100463167B1
(ko)
*
|
2001-04-13 |
2004-12-23 |
주식회사 태평양 |
고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
US7153703B2
(en)
*
|
2001-05-14 |
2006-12-26 |
Board Of Trustees Of The University Of Arkansas N. A. |
Synthesis of stable colloidal nanocrystals using organic dendrons
|
EA007408B1
(ru)
|
2001-05-21 |
2006-10-27 |
Нектар Терапьютикс |
Легочное введение химически модифицированного инсулина
|
AU2002320058A1
(en)
*
|
2001-06-06 |
2002-12-16 |
The General Hspital Corporation |
Magnetic-nanoparticle conjugates and methods of use
|
JP4342934B2
(ja)
*
|
2001-06-11 |
2009-10-14 |
キセノポート インコーポレーティッド |
Pept−2輸送体を介した薬剤の投与
|
DE60237449D1
(de)
*
|
2001-06-22 |
2010-10-07 |
Univ Johns Hopkins Med |
Ammensetzungen und damit in beziehung stehende verwendungen
|
US7498045B2
(en)
*
|
2001-08-31 |
2009-03-03 |
Thomas M. S. Chang |
Biodegradable polymeric nanocapsules and uses thereof
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
CA2461349C
(en)
|
2001-09-26 |
2011-11-29 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
CN1303155C
(zh)
*
|
2001-10-18 |
2007-03-07 |
株式会社三养社 |
具有改进稳定性的聚合物胶束组合物
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
EP1458365A1
(de)
*
|
2001-12-21 |
2004-09-22 |
Celator Technologies Inc. |
Verbesserte polymer-lipid arzneiverabreichungsträger
|
US9770517B2
(en)
|
2002-03-01 |
2017-09-26 |
Immunomedics, Inc. |
Anti-Trop-2 antibody-drug conjugates and uses thereof
|
AU2003224808A1
(en)
*
|
2002-03-28 |
2003-10-13 |
Imcor Pharmaceutical Company |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
US6919068B2
(en)
*
|
2002-05-17 |
2005-07-19 |
Point Biomedical Corporation |
Method of preparing gas-filled polymer matrix microparticles useful for echographic imaging
|
US7670623B2
(en)
|
2002-05-31 |
2010-03-02 |
Materials Modification, Inc. |
Hemostatic composition
|
US7297348B2
(en)
*
|
2002-07-19 |
2007-11-20 |
Omeros Corporation |
Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from
|
FR2842737B1
(fr)
*
|
2002-07-25 |
2006-01-27 |
Centre Nat Rech Scient |
Particules revetues en surface de hyaluronane ou d'un de ses derives et leur utilisation a titre de vecteurs biologiques pour des matieres actives
|
US20040028804A1
(en)
*
|
2002-08-07 |
2004-02-12 |
Anderson Daniel G. |
Production of polymeric microarrays
|
WO2004065362A2
(en)
*
|
2002-08-16 |
2004-08-05 |
University Of Massachusetts |
Pyridine and related ligand compounds, functionalized nanoparticulate composites and methods of preparation
|
US7273904B2
(en)
|
2002-10-03 |
2007-09-25 |
The Board Of Trustees Of The University Of Arkansas |
Nanocrystals in ligand boxes exhibiting enhanced chemical, photochemical, and thermal stability, and methods of making the same
|
US20040161424A1
(en)
*
|
2002-10-08 |
2004-08-19 |
Xenoport |
Human organic solute transporters
|
US20040086432A1
(en)
*
|
2002-10-31 |
2004-05-06 |
Labarge William J. |
Reformer, systems utilizing the reformer, and methods for operating the systems
|
US7094730B2
(en)
*
|
2002-10-31 |
2006-08-22 |
Delphi Technologies, Inc. |
Gas treatment device, methods for making and using the same, and a vehicle exhaust system
|
CA2506129C
(en)
|
2002-11-15 |
2015-02-17 |
Idenix (Cayman) Limited |
2'-branched nucleosides and flaviviridae mutation
|
US7560160B2
(en)
|
2002-11-25 |
2009-07-14 |
Materials Modification, Inc. |
Multifunctional particulate material, fluid, and composition
|
US8420086B2
(en)
|
2002-12-13 |
2013-04-16 |
Immunomedics, Inc. |
Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
|
US7007972B1
(en)
|
2003-03-10 |
2006-03-07 |
Materials Modification, Inc. |
Method and airbag inflation apparatus employing magnetic fluid
|
US20040185108A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Short Robert E. |
Method of preparing gas-filled polymer matrix microparticles useful for delivering drug
|
US7645512B1
(en)
*
|
2003-03-31 |
2010-01-12 |
The Research Foundation Of The State University Of New York |
Nano-structure enhancements for anisotropic conductive adhesive and thermal interposers
|
US8518304B1
(en)
|
2003-03-31 |
2013-08-27 |
The Research Foundation Of State University Of New York |
Nano-structure enhancements for anisotropic conductive material and thermal interposers
|
WO2004089345A1
(en)
*
|
2003-04-03 |
2004-10-21 |
Semafore Pharmaceuticals Inc. |
Bone targeting of biodegradable drug-containing nanoparticles
|
US7430445B2
(en)
*
|
2003-04-24 |
2008-09-30 |
The Board Of Regents Of The University Of Texas System |
Noninvasive blood analysis by optical probing of the veins under the tongue
|
US20040224030A1
(en)
*
|
2003-05-06 |
2004-11-11 |
Shastri Venkatram R. |
Microsphere delivery systems
|
US6982501B1
(en)
|
2003-05-19 |
2006-01-03 |
Materials Modification, Inc. |
Magnetic fluid power generator device and method for generating power
|
US7723311B2
(en)
*
|
2003-06-18 |
2010-05-25 |
Nanobiomagnetics, Inc. |
Delivery of bioactive substances to target cells
|
US8651113B2
(en)
*
|
2003-06-18 |
2014-02-18 |
Swr&D Inc. |
Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
|
US7344491B1
(en)
|
2003-11-26 |
2008-03-18 |
Nanobiomagnetics, Inc. |
Method and apparatus for improving hearing
|
US20040258614A1
(en)
*
|
2003-06-20 |
2004-12-23 |
University Of Maryland, Baltimore |
Microparticles for microarterial imaging and radiotherapy
|
ES2226567B1
(es)
*
|
2003-06-20 |
2006-07-01 |
Universidad De Santiago De Compostela |
Nanoparticulas de acido hialuronico.
|
US7344887B2
(en)
*
|
2003-06-24 |
2008-03-18 |
Johns Hopkins University |
Methods and products for delivering biological molecules to cells using multicomponent nanostructures
|
ES2232287B1
(es)
*
|
2003-07-04 |
2006-11-01 |
Advanced In Vitro Cell Technologies, S.L. |
Nanoparticulas de derivados polioxietilenados.
|
US7200956B1
(en)
|
2003-07-23 |
2007-04-10 |
Materials Modification, Inc. |
Magnetic fluid cushioning device for a footwear or shoe
|
US7790141B2
(en)
*
|
2003-08-11 |
2010-09-07 |
Pathak Holdings, Llc |
Radio-opaque compounds, compositions containing same and methods of their synthesis and use
|
US20050042298A1
(en)
*
|
2003-08-20 |
2005-02-24 |
Pardridge William M. |
Immunonanoparticles
|
US20050136536A1
(en)
*
|
2003-09-15 |
2005-06-23 |
Anderson Daniel G. |
Embryonic epithelial cells
|
US7448389B1
(en)
|
2003-10-10 |
2008-11-11 |
Materials Modification, Inc. |
Method and kit for inducing hypoxia in tumors through the use of a magnetic fluid
|
US20050084513A1
(en)
*
|
2003-10-21 |
2005-04-21 |
Board Of Regents |
Nanocoating for improving biocompatibility of medical implants
|
WO2005041897A2
(en)
|
2003-10-31 |
2005-05-12 |
Point Biomedical Corporation |
Reconstitutable microsphere compositions useful as ultrasonic contrast agents
|
US7608240B2
(en)
*
|
2003-12-05 |
2009-10-27 |
Board Of Trustees Of The University Of Arkansas |
Nanotubes for cancer therapy and diagnostics
|
WO2005061724A1
(en)
*
|
2003-12-10 |
2005-07-07 |
The General Hospital Corporation |
Self-assembling nanoparticle conjugates
|
WO2005072710A2
(en)
*
|
2004-01-28 |
2005-08-11 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
EP1711163A2
(de)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Unter verwendung von selbststabilisierenden mitteln hergestellte dispersionen
|
US9550838B2
(en)
|
2004-02-13 |
2017-01-24 |
Ibc Pharmaceuticals, Inc. |
Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
|
US8883160B2
(en)
*
|
2004-02-13 |
2014-11-11 |
Ibc Pharmaceuticals, Inc. |
Dock-and-lock (DNL) complexes for therapeutic and diagnostic use
|
US7632784B2
(en)
*
|
2004-04-17 |
2009-12-15 |
Rokhvarger Anatoly E |
Sintered ceramic composite lead with superconductive nano-architecture
|
ES2246694B1
(es)
*
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
ES2246695B1
(es)
*
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
|
US8012457B2
(en)
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
US20080280973A1
(en)
*
|
2004-06-28 |
2008-11-13 |
Wender Paul A |
Laulimalide Analogues as Therapeutic Agents
|
JP2008512350A
(ja)
*
|
2004-07-01 |
2008-04-24 |
イェール ユニバーシティ |
標的化され、そして高密度で薬物が負荷されるポリマー性物質
|
WO2006085987A2
(en)
|
2004-07-09 |
2006-08-17 |
University Of Iowa Research Foundation |
Rna interference in respiratory epitheial cells
|
EP1786443B1
(de)
*
|
2004-07-19 |
2018-06-06 |
Celator Pharmaceuticals, Inc. |
Teilchenförmige konstrukte zur freisetzung von wirkstoffen
|
US8357391B2
(en)
|
2004-07-30 |
2013-01-22 |
Advanced Cardiovascular Systems, Inc. |
Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages
|
AU2005292083A1
(en)
*
|
2004-09-29 |
2006-04-13 |
Alza Corporation |
Microparticles and nanoparticles containing a lipopolymer
|
WO2007001448A2
(en)
*
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US20060198891A1
(en)
*
|
2004-11-29 |
2006-09-07 |
Francois Ravenelle |
Solid formulations of liquid biologically active agents
|
US8394410B2
(en)
*
|
2005-01-20 |
2013-03-12 |
Massachusetts Institute Of Technology |
Soft polylactides
|
US7611494B2
(en)
*
|
2005-02-08 |
2009-11-03 |
Confluent Surgical, Inc. |
Spray for fluent materials
|
US10058621B2
(en)
|
2015-06-25 |
2018-08-28 |
Immunomedics, Inc. |
Combination therapy with anti-HLA-DR antibodies and kinase inhibitors in hematopoietic cancers
|
CN101171034B
(zh)
|
2005-03-03 |
2014-06-18 |
免疫医疗公司 |
人源化l243抗体
|
US9707302B2
(en)
|
2013-07-23 |
2017-07-18 |
Immunomedics, Inc. |
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer
|
US8003079B2
(en)
*
|
2005-04-05 |
2011-08-23 |
Bar-Ilan University |
Core and core-shell nanoparticles containing iodine for X-ray imaging
|
US8349332B2
(en)
|
2005-04-06 |
2013-01-08 |
Ibc Pharmaceuticals, Inc. |
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
|
US8475794B2
(en)
|
2005-04-06 |
2013-07-02 |
Ibc Pharmaceuticals, Inc. |
Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases
|
KR100806669B1
(ko)
|
2005-06-23 |
2008-02-26 |
김정환 |
나노 입자-생체 복합체
|
CN101227940A
(zh)
*
|
2005-07-25 |
2008-07-23 |
纳米技术维多利亚有限公司 |
微阵列装置
|
US20070031512A1
(en)
*
|
2005-08-03 |
2007-02-08 |
Amcol International Corporation |
Virus-interacting layered phyllosilicates and methods of inactivating viruses
|
US20080184618A1
(en)
*
|
2005-08-03 |
2008-08-07 |
Amcol International |
Virus-Interacting Layered Phyllosilicates and Methods of Use
|
US20100272769A1
(en)
*
|
2005-08-03 |
2010-10-28 |
Amcol International |
Virus-, Bacteria-, and Fungi-Interacting Layered Phyllosilicates and Methods of Use
|
WO2007027843A2
(en)
*
|
2005-08-31 |
2007-03-08 |
T2 Biosystems, Inc. |
Nmr device for detection of analytes involving magnetic particles
|
KR100718329B1
(ko)
*
|
2005-09-08 |
2007-05-14 |
광주과학기술원 |
다당류로 기능화된 수화젤막을 가지는 나노입자와 이를포함하는 서방형 약물전달시스템 및 그 제조방법
|
US20070248675A1
(en)
*
|
2005-09-08 |
2007-10-25 |
Gwangju Institute Of Science And Technology |
Composite comprising polysaccharide-functionalized nanoparticle and hydrogel matrix, a drug delivery system and a bone defect replacement matrix for sustained release comprising the same, and the preparation method thereof
|
US20070264199A1
(en)
*
|
2005-09-26 |
2007-11-15 |
Labhasetwar Vinod D |
Magnetic nanoparticle composition and methods for using the same
|
US20070071683A1
(en)
*
|
2005-09-27 |
2007-03-29 |
The Regents Of The University Of California |
Ultrasonic concentration of carrier particles
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
EP2674440B1
(de)
|
2005-12-16 |
2019-07-03 |
IBC Pharmaceuticals, Inc. |
Polyvalente bioaktive anordnungen auf immunglobulinbasis
|
US20070156230A1
(en)
|
2006-01-04 |
2007-07-05 |
Dugan Stephen R |
Stents with radiopaque markers
|
US8021689B2
(en)
*
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
AU2013205838B2
(en)
*
|
2006-02-21 |
2016-03-17 |
Avrum Belzer |
Hyperpolarization Methods, Systems and Compositions
|
AU2007254464B2
(en)
*
|
2006-02-21 |
2013-02-21 |
Avrum Belzer |
Hyperpolarization methods, systems and compositions
|
WO2007097593A1
(en)
*
|
2006-02-24 |
2007-08-30 |
Atgen Co., Ltd. |
Magnetic nano-composite for contrast agent, intelligent contrast agent, drug delivery agent for simultaneous diagnosis and treatment, and separation agent for target substance
|
US20070218007A1
(en)
*
|
2006-03-17 |
2007-09-20 |
Allergan, Inc. |
Ophthalmic visualization compositions and methods of using same
|
US20070225472A1
(en)
*
|
2006-03-23 |
2007-09-27 |
Varshney Sunil K |
Polyanhydride polymers and their uses in biomedical devices
|
WO2008105773A2
(en)
|
2006-03-31 |
2008-09-04 |
Massachusetts Institute Of Technology |
System for targeted delivery of therapeutic agents
|
CA2652280C
(en)
|
2006-05-15 |
2014-01-28 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
US8752268B2
(en)
|
2006-05-26 |
2014-06-17 |
Abbott Cardiovascular Systems Inc. |
Method of making stents with radiopaque markers
|
AU2007256626A1
(en)
|
2006-06-06 |
2007-12-13 |
Rutgers, The State University Of New Jersey |
Iodinated polymers
|
US8535372B1
(en)
|
2006-06-16 |
2013-09-17 |
Abbott Cardiovascular Systems Inc. |
Bioabsorbable stent with prohealing layer
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
US8128688B2
(en)
|
2006-06-27 |
2012-03-06 |
Abbott Cardiovascular Systems Inc. |
Carbon coating on an implantable device
|
US7823263B2
(en)
|
2006-07-11 |
2010-11-02 |
Abbott Cardiovascular Systems Inc. |
Method of removing stent islands from a stent
|
EP2044140B1
(de)
|
2006-07-20 |
2017-05-17 |
OrbusNeich Medical, Inc. |
Bioresorbierbare polymerzusammensetzung für eine medizinische vorrichtung
|
US8016879B2
(en)
|
2006-08-01 |
2011-09-13 |
Abbott Cardiovascular Systems Inc. |
Drug delivery after biodegradation of the stent scaffolding
|
JP4881385B2
(ja)
*
|
2006-08-30 |
2012-02-22 |
国立大学法人九州大学 |
スタチン封入ナノ粒子含有医薬組成物
|
EP2061433B1
(de)
*
|
2006-09-08 |
2011-02-16 |
Johns Hopkins University |
Zusammensetzungen zur transportintensivierung durch die schleimhaut
|
WO2008038944A1
(en)
*
|
2006-09-26 |
2008-04-03 |
Samyang Corporation |
Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof
|
US7959942B2
(en)
|
2006-10-20 |
2011-06-14 |
Orbusneich Medical, Inc. |
Bioabsorbable medical device with coating
|
WO2008070304A2
(en)
|
2006-10-20 |
2008-06-12 |
Orbusneich Medical, Inc. |
Bioabsorbable polymeric composition and medical device background
|
US20110223232A1
(en)
*
|
2006-10-23 |
2011-09-15 |
Olexander Hnojewyj |
drug-release composition having a therapeutic carrier
|
WO2008084286A2
(en)
|
2006-10-25 |
2008-07-17 |
Arterial Remodeling Technologies, S.A. |
Method for expansion and deployment of polymeric structures including stents
|
US10149935B2
(en)
*
|
2006-11-27 |
2018-12-11 |
Frank Levy |
Delivery system and method for the effective and reliable delivery of controlled amounts of a medical fluid
|
US11712510B2
(en)
|
2006-11-27 |
2023-08-01 |
Frank Levy |
Delivery system and method for the effective, reliable and foolproof delivery of controlled amounts of a medical fluid
|
WO2008091465A2
(en)
*
|
2006-12-21 |
2008-07-31 |
Wayne State University |
Peg and targeting ligands on nanoparticle surface
|
KR100809402B1
(ko)
|
2007-01-29 |
2008-03-05 |
김정환 |
나노 입자 표지, 나노 입자 표지를 이용하는 진단 키트, 및진단 방법
|
GB0701896D0
(en)
|
2007-02-01 |
2007-03-14 |
Regentec Ltd |
Composition
|
WO2008098165A2
(en)
|
2007-02-09 |
2008-08-14 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
US10265407B2
(en)
|
2007-02-15 |
2019-04-23 |
Yale University |
Modular nanodevices for smart adaptable vaccines
|
US8889117B2
(en)
|
2007-02-15 |
2014-11-18 |
Yale University |
Modular nanoparticles for adaptable vaccines
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
EP2144600A4
(de)
|
2007-04-04 |
2011-03-16 |
Massachusetts Inst Technology |
Poly (aminsäure)-zielmoleküle
|
US8703204B2
(en)
|
2007-05-03 |
2014-04-22 |
Bend Research, Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
|
US8309129B2
(en)
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
DK2167069T3
(da)
|
2007-05-23 |
2011-11-21 |
Amcol International Corp |
Cholesterol-interagerende lagdelte phyllosilikater og fremgangsmåder til at reducere hypercholesterolæmi hos et pattedyr
|
EP2162120B1
(de)
|
2007-06-04 |
2016-05-04 |
Bend Research, Inc |
Nanopartikel mit nicht ionisierbarem zellulosepolymer und amphipilem nicht ionisierbarem blockcopolymer
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
US7901452B2
(en)
|
2007-06-27 |
2011-03-08 |
Abbott Cardiovascular Systems Inc. |
Method to fabricate a stent having selected morphology to reduce restenosis
|
US7955381B1
(en)
|
2007-06-29 |
2011-06-07 |
Advanced Cardiovascular Systems, Inc. |
Polymer-bioceramic composite implantable medical device with different types of bioceramic particles
|
US9125807B2
(en)
*
|
2007-07-09 |
2015-09-08 |
Incept Llc |
Adhesive hydrogels for ophthalmic drug delivery
|
WO2009012372A1
(en)
|
2007-07-18 |
2009-01-22 |
Advantageous Systems, Llc |
Methods and apparatuses for detecting analytes in biological fluid of an animal
|
US9097644B2
(en)
*
|
2007-08-17 |
2015-08-04 |
Massachusetts Institute Of Technology |
Magnetic resonance-based viscometers and methods
|
SG150405A1
(en)
*
|
2007-08-29 |
2009-03-30 |
Agency Science Tech & Res |
Method of coating a particle
|
DK2644192T3
(en)
|
2007-09-28 |
2017-06-26 |
Pfizer |
Cancer cell targeting using nanoparticles
|
ES2627233T3
(es)
|
2007-10-12 |
2017-07-27 |
Massachusetts Institute Of Technology |
Nanotecnología de vacunas
|
EP2231169B1
(de)
|
2007-12-06 |
2016-05-04 |
Bend Research, Inc. |
Pharmazeutische zusammensetzungen mit nanopartikeln und resuspensionsmaterial
|
WO2009073216A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
|
US20110027172A1
(en)
*
|
2007-12-10 |
2011-02-03 |
Zhuang Wang |
Drug delivery system for pharmaceuticals and radiation
|
EP2222281B1
(de)
|
2007-12-20 |
2018-12-05 |
Evonik Corporation |
Verfahren zur herstellung von mikropartikeln mit geringer restlösemittelmenge
|
CN102105554A
(zh)
*
|
2008-06-10 |
2011-06-22 |
阿肯色大学托管委员会 |
砷化铟纳米晶体及其制备方法
|
CA2728176C
(en)
|
2008-06-16 |
2017-07-04 |
Bind Biosciences, Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
ES2721850T3
(es)
*
|
2008-06-16 |
2019-08-05 |
Pfizer |
Nanopartículas poliméricas terapéuticas que comprenden alcaloides vinca y procedimientos de fabricación y uso de las mismas
|
US8613951B2
(en)
|
2008-06-16 |
2013-12-24 |
Bind Therapeutics, Inc. |
Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
|
US20100055041A1
(en)
*
|
2008-08-28 |
2010-03-04 |
Dong June Ahn |
Nanotracer for in-situ gastric cancer detection
|
US9861096B2
(en)
*
|
2008-10-01 |
2018-01-09 |
Cornell University |
Biodegradable chemical delivery system
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8563041B2
(en)
|
2008-12-12 |
2013-10-22 |
Bind Therapeutics, Inc. |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
JP2012512175A
(ja)
|
2008-12-15 |
2012-05-31 |
バインド バイオサイエンシズ インコーポレイテッド |
治療薬を徐放するための長時間循環性ナノ粒子
|
CA2750242C
(en)
|
2009-02-12 |
2018-05-22 |
Incept, Llc |
Drug delivery through hydrogel plugs
|
US8580230B2
(en)
*
|
2009-02-23 |
2013-11-12 |
Kent State University |
Materials and methods for MRI contrast agents and drug delivery
|
CA2756072A1
(en)
*
|
2009-03-30 |
2010-10-14 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
WO2010114770A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
WO2010114768A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
CA2757645C
(en)
*
|
2009-04-06 |
2018-05-15 |
Mayo Foundation For Medical Education And Research |
Methods and materials for delivering molecules
|
AU2010254551B2
(en)
|
2009-05-27 |
2016-10-20 |
Selecta Biosciences, Inc. |
Immunomodulatory agent-polymeric compounds
|
CN107715118A
(zh)
|
2009-08-26 |
2018-02-23 |
西莱克塔生物科技公司 |
诱导t细胞辅助的组合物
|
US9205155B2
(en)
|
2009-10-30 |
2015-12-08 |
General Electric Company |
Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents
|
TR201906255T4
(tr)
|
2009-12-11 |
2019-05-21 |
Pfizer |
Terapötik partiküllerin liyofilize edilmesine yönelik stabil formülasyonlar.
|
JP5965844B2
(ja)
|
2009-12-15 |
2016-08-10 |
バインド セラピューティックス インコーポレイテッド |
高いガラス転移温度または高分子量のコポリマーを有する治療用ポリマーナノ粒子組成物
|
EP3960215A1
(de)
|
2009-12-15 |
2022-03-02 |
Incept, LLC |
Implantate und biologisch abbaubare bezugsmarkierungen
|
EP2512487A4
(de)
*
|
2009-12-15 |
2013-08-07 |
|
Therapeutische polymernanopartikel mit corticosteroiden sowie verfahren zu deren herstellung und verwendung
|
US20130017265A1
(en)
*
|
2009-12-16 |
2013-01-17 |
Massachusetts Institute Of Technology |
Particles for multiple agent delivery
|
US9089512B2
(en)
|
2009-12-18 |
2015-07-28 |
President And Fellows Of Harvard College |
Active scaffolds for on-demand drug and cell delivery
|
EP2523680A4
(de)
*
|
2010-01-11 |
2013-06-19 |
Ct Molecular Med & Immunology |
Verstärkte zytotoxizität von antikörpern gegen cd74 und hla-dr mit interferon-gamma
|
US8808353B2
(en)
|
2010-01-30 |
2014-08-19 |
Abbott Cardiovascular Systems Inc. |
Crush recoverable polymer scaffolds having a low crossing profile
|
US8568471B2
(en)
|
2010-01-30 |
2013-10-29 |
Abbott Cardiovascular Systems Inc. |
Crush recoverable polymer scaffolds
|
US8889193B2
(en)
|
2010-02-25 |
2014-11-18 |
The Johns Hopkins University |
Sustained delivery of therapeutic agents to an eye compartment
|
EP2552412A2
(de)
*
|
2010-03-26 |
2013-02-06 |
Evonik Degussa Corporation |
Emulsionen zur mikroverkapselung mit biologisc abbaubaren oberflächenaktiven blockcopolymeren als stabilisatoren
|
US8808357B2
(en)
*
|
2010-04-06 |
2014-08-19 |
Poly-Med, Inc. |
Radiopaque iodinated and iodide-containing crystalline absorbable aliphatic polymeric materials and applications thereof
|
NO2575876T3
(de)
|
2010-05-26 |
2018-05-05 |
|
|
US9364568B2
(en)
*
|
2010-07-15 |
2016-06-14 |
Warsaw Orthopedic, Inc. |
Methods to diagnose degenerative disc disease
|
EA201390144A1
(ru)
*
|
2010-08-20 |
2013-06-28 |
Серулин Фарма Инк. |
Конъюгаты терапевтический пептид-полимер, частицы, композиции и связанные с ними способы
|
AU2011337139B2
(en)
|
2010-08-30 |
2015-11-12 |
President And Fellows Of Harvard College |
Shear controlled release for stenotic lesions and thrombolytic therapies
|
US10307372B2
(en)
|
2010-09-10 |
2019-06-04 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
US8961501B2
(en)
|
2010-09-17 |
2015-02-24 |
Incept, Llc |
Method for applying flowable hydrogels to a cornea
|
WO2012051220A1
(en)
*
|
2010-10-11 |
2012-04-19 |
Wichita State University |
Composite magnetic nanoparticle drug delivery system
|
WO2012054639A2
(en)
|
2010-10-22 |
2012-04-26 |
T2 Biosystems, Inc. |
Nmr systems and methods for the rapid detection of analytes
|
US8409807B2
(en)
|
2010-10-22 |
2013-04-02 |
T2 Biosystems, Inc. |
NMR systems and methods for the rapid detection of analytes
|
US8563298B2
(en)
|
2010-10-22 |
2013-10-22 |
T2 Biosystems, Inc. |
NMR systems and methods for the rapid detection of analytes
|
EP2640190A4
(de)
|
2010-11-05 |
2016-05-11 |
Selecta Biosciences Inc |
Modifizierte nikotinische verbindungen und zugehörige verfahren
|
EP3586825B1
(de)
|
2010-12-29 |
2023-01-18 |
Medincell S.A. |
Biologisch abbaubare wirkstofffreisetzungszusammensetzungen
|
WO2012105984A1
(en)
*
|
2011-02-04 |
2012-08-09 |
Empire Technology Development Llc |
Materials, monitoring, and controlling tissue growth using magnetic nanoparticles
|
WO2012109363A2
(en)
|
2011-02-08 |
2012-08-16 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
US9713702B2
(en)
*
|
2011-03-14 |
2017-07-25 |
The Board Of Trustee Of The Leland Stanford Junior University |
Methods of electric field induced delivery of compounds, compositions used in delivery, and systems of delivery
|
US9801829B2
(en)
*
|
2011-04-29 |
2017-10-31 |
University Of Florida Research Foundation, Inc. |
Methods and systems of making nanostructures
|
KR20230006042A
(ko)
|
2011-04-29 |
2023-01-10 |
셀렉타 바이오사이언시즈, 인크. |
항체 반응을 감소시키기 위한 관용원성 합성 나노운반체
|
EP2706989A1
(de)
*
|
2011-05-09 |
2014-03-19 |
Instituto Químico De Sarrià |
Polymere nanopartikel zur wirkstofffreisetzung
|
US9593160B2
(en)
|
2011-07-18 |
2017-03-14 |
President And Fellows Of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
US8726483B2
(en)
|
2011-07-29 |
2014-05-20 |
Abbott Cardiovascular Systems Inc. |
Methods for uniform crimping and deployment of a polymer scaffold
|
CA2843274A1
(en)
|
2011-07-29 |
2013-02-07 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
CN104185420B
(zh)
|
2011-11-30 |
2017-06-09 |
埃默里大学 |
用于治疗或预防逆转录病毒和其它病毒感染的抗病毒jak抑制剂
|
US9757458B2
(en)
|
2011-12-05 |
2017-09-12 |
Immunomedics, Inc. |
Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells
|
EP2788020A4
(de)
|
2011-12-05 |
2015-04-29 |
Immunomedics Inc |
Therapeutische verwendung von anti-cd22-antikörpern zur induktion von trogozytose
|
CN104936620B
(zh)
|
2012-01-19 |
2019-08-09 |
约翰霍普金斯大学 |
增强粘膜渗透的纳米粒子调配物
|
US8927529B2
(en)
|
2012-01-30 |
2015-01-06 |
SpineThera |
Treatment of back pain by injection of microparticles of dexamethasone acetate and a polymer
|
US20130236504A1
(en)
|
2012-03-06 |
2013-09-12 |
Medical University Of South Carolina |
Delivery System for Enhancing Drug Efficacy
|
EP2825207B1
(de)
*
|
2012-03-16 |
2020-08-19 |
The Johns Hopkins University |
Nichtlineare multiblock-copolymer-arzneimittelkonjugate zur verabreichung von wirkstoffen
|
WO2013138343A1
(en)
|
2012-03-16 |
2013-09-19 |
The Johns Hopkins University |
Controlled release formulations for the delivery of hif-1 inhibitors
|
WO2013158281A1
(en)
|
2012-04-20 |
2013-10-24 |
T2 Biosystems, Inc. |
Compositions and methods for detection of candida species
|
US9597385B2
(en)
|
2012-04-23 |
2017-03-21 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US10688041B2
(en)
|
2012-05-03 |
2020-06-23 |
Kala Pharmaceuticals, Inc. |
Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
AU2013256130B2
(en)
|
2012-05-03 |
2017-12-21 |
Alcon Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
US9889208B2
(en)
|
2012-05-04 |
2018-02-13 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
US9533068B2
(en)
|
2012-05-04 |
2017-01-03 |
The Johns Hopkins University |
Drug loaded microfiber sutures for ophthalmic application
|
SI2895156T1
(sl)
|
2012-09-17 |
2019-08-30 |
Pfizer Inc. |
Postopek za pripravo terapevtskih nanodelcev
|
CN103830741B
(zh)
*
|
2012-11-27 |
2019-02-19 |
杨子剑 |
含有陶扎色替类似物结构的化合物以及制备方法和用途
|
CN103848901A
(zh)
*
|
2012-11-28 |
2014-06-11 |
杨子剑 |
含有万古霉素结构的新化合物以及制备方法和用途
|
CN103848986B
(zh)
*
|
2012-11-28 |
2019-10-11 |
杨子剑 |
含有头孢菌素结构的化合物以及制备方法和用途
|
CN103848894A
(zh)
*
|
2012-11-30 |
2014-06-11 |
杨子剑 |
含有达托霉素结构的新化合物以及制备方法和用途
|
US10206918B2
(en)
|
2012-12-13 |
2019-02-19 |
Immunomedics, Inc. |
Efficacy of anti-HLA-DR antiboddy drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers
|
US10413539B2
(en)
|
2012-12-13 |
2019-09-17 |
Immunomedics, Inc. |
Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)
|
CN107753954A
(zh)
|
2012-12-13 |
2018-03-06 |
免疫医疗公司 |
功效改进且毒性降低的抗体与sn‑38的免疫缀合物的剂量
|
US10744129B2
(en)
|
2012-12-13 |
2020-08-18 |
Immunomedics, Inc. |
Therapy of small-cell lung cancer (SCLC) with a topoisomerase-I inhibiting antibody-drug conjugate (ADC) targeting Trop-2
|
WO2015012904A2
(en)
|
2012-12-13 |
2015-01-29 |
Immunomedics, Inc. |
Antibody-sn-38 immunoconjugates with a cl2a linker
|
US9492566B2
(en)
|
2012-12-13 |
2016-11-15 |
Immunomedics, Inc. |
Antibody-drug conjugates and uses thereof
|
US9931417B2
(en)
|
2012-12-13 |
2018-04-03 |
Immunomedics, Inc. |
Antibody-SN-38 immunoconjugates with a CL2A linker
|
US10137196B2
(en)
|
2012-12-13 |
2018-11-27 |
Immunomedics, Inc. |
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity
|
WO2014124006A1
(en)
|
2013-02-05 |
2014-08-14 |
The Johns Hopkins University |
Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
|
US9468681B2
(en)
|
2013-03-01 |
2016-10-18 |
California Institute Of Technology |
Targeted nanoparticles
|
US10551379B2
(en)
|
2013-03-15 |
2020-02-04 |
President And Fellows Of Harvard College |
Methods and compositions for improving detection and/or capture of a target entity
|
EP2981285B1
(de)
|
2013-04-03 |
2020-06-03 |
N-Fold Llc |
Neuartige nanopartikelzusammensetzungen
|
CN110841067A
(zh)
|
2013-05-03 |
2020-02-28 |
西莱克塔生物科技公司 |
用于降低的或增强的药效学作用的致耐受性合成纳米载体和治疗性大分子
|
JP6649250B2
(ja)
|
2013-05-21 |
2020-02-19 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
操作されたヘム結合性構成物およびその使用
|
EP3003306B1
(de)
|
2013-06-04 |
2020-08-26 |
Selecta Biosciences, Inc. |
Wiederholte verabreichung von nicht-immunosupressiven antigenspezifischen immuntherapeutika
|
US11253606B2
(en)
|
2013-07-23 |
2022-02-22 |
Immunomedics, Inc. |
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PARP inhibitors, Bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer
|
CN105037710A
(zh)
*
|
2013-09-01 |
2015-11-11 |
韩冰 |
新化合物的制备方法及其在医疗中的新用途
|
MX370490B
(es)
|
2013-09-16 |
2019-12-16 |
Astrazeneca Ab |
Nanopartículas poliméricas terapéuticas y métodos para su elaboración y uso.
|
US10513546B2
(en)
|
2013-12-18 |
2019-12-24 |
President And Fellows Of Harvard College |
CRP capture/detection of gram positive bacteria
|
WO2015127389A1
(en)
|
2014-02-23 |
2015-08-27 |
The Johns Hopkins University |
Hypotonic enema formulations and methods of use
|
DK3511019T3
(da)
|
2014-03-14 |
2020-10-26 |
Pfizer |
Terapeutiske nanopartikler omfattende et terapeutisk middel og fremgangsmåder til fremstilling og anvendelse deraf
|
US10335500B2
(en)
|
2014-05-12 |
2019-07-02 |
The Johns Hopkins University |
Highly stable biodegradable gene vector platforms for overcoming biological barriers
|
US10029997B2
(en)
|
2014-06-12 |
2018-07-24 |
Cedars-Sinai Medical Center |
Compositions and methods for treating cancers
|
WO2015200054A2
(en)
|
2014-06-24 |
2015-12-30 |
The Trustees Of Princeton University |
Process for encapsulating soluble biologics, therapeutics, and imaging agents
|
AU2015279738A1
(en)
|
2014-06-25 |
2016-12-22 |
Selecta Biosciences, Inc. |
Methods and compositions for treatment with synthetic nanocarriers and immune checkpoint inhibitors
|
KR102270242B1
(ko)
|
2014-09-02 |
2021-06-25 |
엘에스아이 메디엔스 코포레이션 |
생리 활성 물질 담지용 고분자 미립자 및 그 제조 방법
|
CN107073091A
(zh)
|
2014-09-07 |
2017-08-18 |
西莱克塔生物科技公司 |
用于减弱外显子跳读抗病毒转移载体免疫应答的方法和组合物
|
US20160128987A1
(en)
|
2014-11-05 |
2016-05-12 |
Selecta Biosciences, Inc. |
Methods and compositions related to synthetic nanocarriers with rapamycin in a stable, super-saturated state
|
NZ733130A
(en)
*
|
2014-12-15 |
2018-09-28 |
Univ Johns Hopkins |
Sunitinib formulations and methods for use thereof in treatment of ocular disorders
|
WO2016123125A1
(en)
|
2015-01-27 |
2016-08-04 |
The Johns Hopkins University |
Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
|
US9999527B2
(en)
|
2015-02-11 |
2018-06-19 |
Abbott Cardiovascular Systems Inc. |
Scaffolds having radiopaque markers
|
US9737368B2
(en)
|
2015-02-24 |
2017-08-22 |
Abbott Cardiovascular Systems Inc. |
System and method for attaching a radiopaque marker bead to an endoprosthesis
|
CN107428837A
(zh)
|
2015-04-22 |
2017-12-01 |
免疫医疗公司 |
循环trop‑2阳性癌细胞的分离、检测、诊断和/或鉴定
|
US9700443B2
(en)
|
2015-06-12 |
2017-07-11 |
Abbott Cardiovascular Systems Inc. |
Methods for attaching a radiopaque marker to a scaffold
|
US10195175B2
(en)
|
2015-06-25 |
2019-02-05 |
Immunomedics, Inc. |
Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors
|
WO2017003668A1
(en)
|
2015-07-01 |
2017-01-05 |
California Institute Of Technology |
Cationic mucic acid polymer-based delivery systems
|
US10435457B2
(en)
|
2015-08-06 |
2019-10-08 |
President And Fellows Of Harvard College |
Microbe-binding molecules and uses thereof
|
AR106018A1
(es)
|
2015-08-26 |
2017-12-06 |
Achillion Pharmaceuticals Inc |
Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
|
EP3340982B1
(de)
|
2015-08-26 |
2021-12-15 |
Achillion Pharmaceuticals, Inc. |
Verbindungen zur behandlung von immun- und entzündungserkrankungen
|
AU2016343840A1
(en)
|
2015-10-30 |
2018-06-07 |
The Johns Hopkins University |
Mucus penetrating particles with high molecular weight and dense coatings
|
CN108367079B
(zh)
|
2015-11-12 |
2022-11-22 |
灰色视觉公司 |
用于治疗的聚集性微粒
|
FI3377041T3
(fi)
|
2015-11-16 |
2023-11-30 |
Medincell S A |
Menetelmä farmaseuttisesti aktiivisten pääainesosien morselloimiseksi ja/tai kohdentamiseksi synoviaalikudokseen
|
WO2017112828A1
(en)
|
2015-12-22 |
2017-06-29 |
The Trustees Of Princeton University |
Process for encapsulating soluble biologics, therapeutics, and imaging agents
|
CA3011901A1
(en)
|
2016-01-21 |
2017-07-27 |
T2 Biosystems, Inc. |
Nmr methods and systems for the rapid detection of bacteria
|
CN108601841A
(zh)
|
2016-02-10 |
2018-09-28 |
免疫医疗公司 |
Abcg2抑制剂与sacituzumab govitecan(immu-132)的组合克服表达trop-2的癌中对sn-38的抗性
|
WO2017147169A1
(en)
|
2016-02-22 |
2017-08-31 |
Ohio State Innovation Foundation |
Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin a analogues or metabolites, and estradiol metabolites
|
JP7417354B2
(ja)
|
2016-03-11 |
2024-01-18 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
ペグ化ウリカーゼの処方物および用量
|
CN105859933B
(zh)
*
|
2016-03-31 |
2018-09-21 |
北京化工大学 |
一种具有核壳结构的反应型聚合物微球及其制备方法和应用
|
WO2017189279A1
(en)
|
2016-04-27 |
2017-11-02 |
Immunomedics, Inc. |
Efficacy of anti-trop-2-sn-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors
|
CN109562107A
(zh)
|
2016-05-10 |
2019-04-02 |
C4医药公司 |
用于靶蛋白降解的杂环降解决定子体
|
WO2017197036A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Spirocyclic degronimers for target protein degradation
|
CN109641874A
(zh)
|
2016-05-10 |
2019-04-16 |
C4医药公司 |
用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
|
MX2018016046A
(es)
|
2016-06-27 |
2019-05-02 |
Achillion Pharmaceuticals Inc |
Quinazolina y compuestos indol para tratar trastornos medicos.
|
EP3478294A4
(de)
|
2016-07-01 |
2020-06-10 |
G1 Therapeutics, Inc. |
Pyrimidinbasierte antiproliferative wirkstoffe
|
US20180085319A1
(en)
|
2016-09-27 |
2018-03-29 |
Takashi Kei Kishimoto |
Methods and compositions for treating cancer
|
EP3541391A4
(de)
|
2016-11-17 |
2020-06-17 |
The University of North Carolina at Chapel Hill |
Alkyl-pyrrolopyrimidin-analoga und verfahren zur herstellung und verwendung davon
|
KR20240015743A
(ko)
|
2017-01-07 |
2024-02-05 |
셀렉타 바이오사이언시즈, 인크. |
합성 나노담체에 커플링된 면역억제제의 패턴화된 투여
|
BR112019018748A2
(pt)
|
2017-03-11 |
2020-04-07 |
Selecta Biosciences Inc |
métodos e composições relacionados ao tratamento combinado com anti-inflamatórios e nanocarreadores sintéticos compreendendo um imunossupressor
|
CN110662543A
(zh)
|
2017-03-23 |
2020-01-07 |
灰色视觉公司 |
用于治疗眼部疾病的药物和组合物
|
CN110392570A
(zh)
|
2017-03-27 |
2019-10-29 |
免疫医疗公司 |
用沙妥珠单抗格维替康和rad51抑制剂治疗表达trop-2的三阴性乳腺癌
|
EP3606964A4
(de)
|
2017-04-03 |
2020-12-09 |
Immunomedics, Inc. |
Subkutane verabreichung von antikörper-arzneimittelkonjugaten zur krebstherapie
|
CA3057875A1
(en)
|
2017-05-10 |
2018-11-15 |
Graybug Vision, Inc. |
Extended release microparticles and suspensions thereof for medical therapy
|
WO2019055539A1
(en)
|
2017-09-12 |
2019-03-21 |
Prudhomme Robert K |
CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME
|
US20190112731A1
(en)
|
2017-10-12 |
2019-04-18 |
Julianne Holloway |
Manufacturing gradient materials using magnetically-assisted electrospinning
|
US20190142974A1
(en)
|
2017-10-13 |
2019-05-16 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector igm responses
|
EP3470056B1
(de)
|
2017-10-16 |
2022-04-27 |
Medtronic Vascular Inc. |
Therapeutische nanopartikel zur behandlung von gefässerkrankungen
|
KR20210018199A
(ko)
|
2018-03-26 |
2021-02-17 |
씨4 테라퓨틱스, 인코포레이티드 |
이카로스의 분해를 위한 세레블론 결합제
|
CN112771070A
(zh)
|
2018-07-16 |
2021-05-07 |
西莱克塔生物科技公司 |
Otc构建体和载体的方法和组合物
|
US20200038463A1
(en)
|
2018-07-16 |
2020-02-06 |
Selecta Biosciences, Inc. |
Methods and compositions of mma constructs and vectors
|
US11731099B2
(en)
|
2018-07-20 |
2023-08-22 |
The Trustees Of Princeton University |
Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation
|
JP2021535112A
(ja)
|
2018-08-20 |
2021-12-16 |
アキリオン ファーマシューティカルズ,インコーポレーテッド |
補体d因子の医学的障害の治療のための医薬化合物
|
EP3866773A4
(de)
|
2018-10-16 |
2022-10-26 |
Georgia State University Research Foundation, Inc. |
Kohlenmonoxid-prodrugs zur behandlung von erkrankungen
|
US10987315B1
(en)
|
2018-12-04 |
2021-04-27 |
University Of South Florida |
Antithrombotic nanoparticles and methods for treating necrotizing enterocolitis
|
US20220106584A1
(en)
|
2019-01-14 |
2022-04-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and kits for generating and selecting a variant of a binding protein with increased binding affinity and/or specificity
|
US20200360453A1
(en)
|
2019-04-28 |
2020-11-19 |
Selecta Biosciences, Inc. |
Methods for treatment of subjects with preexisting immunity to viral transfer vectors
|
US11471412B1
(en)
|
2019-05-10 |
2022-10-18 |
University Of South Florida |
Nanoparticles and nanogel drug compositions for treatment of age-related macular degeneration
|
CN114206396A
(zh)
|
2019-05-28 |
2022-03-18 |
西莱克塔生物科技公司 |
用于减弱抗病毒转移载体免疫应答的方法和组合物
|
US20200399628A1
(en)
|
2019-06-04 |
2020-12-24 |
Selecta Biosciences, Inc. |
Formulations and doses of pegylated uricase
|
CA3158408A1
(en)
|
2019-10-21 |
2021-04-29 |
Selecta Biosciences, Inc. |
Methods and compositions for treating liver diseases and disorders
|
AU2020380944A1
(en)
|
2019-11-08 |
2022-06-02 |
Selecta Biosciences, Inc. |
Formulations and doses of pegylated uricase
|
US20210290601A1
(en)
|
2020-02-26 |
2021-09-23 |
Selecta Biosciences, Inc. |
Methods and compositions using synthetic nanocarriers comprising immunosuppressant
|
WO2021211100A1
(en)
|
2020-04-14 |
2021-10-21 |
Selecta Biosciences, Inc. |
Methods and compositions for inducing autophagy
|
IL296326A
(en)
|
2020-03-11 |
2022-11-01 |
Selecta Biosciences Inc |
Methods and preparations related to synthetic nanocarriers
|
CA3194232A1
(en)
|
2020-09-29 |
2022-04-07 |
Daniel Beard |
Stroke treatment
|
EP4274571A1
(de)
|
2021-01-05 |
2023-11-15 |
Selecta Biosciences, Inc. |
Dosierungsprotokolle für virale vektoren
|
KR20230167405A
(ko)
|
2021-04-09 |
2023-12-08 |
셀렉타 바이오사이언시즈, 인크. |
면역 관용을 증진시키기 위해 고친화도 il-2 수용체 효능제와 조합된 면역억제제를 포함하는 합성 나노담체
|
CA3235269A1
(en)
|
2021-10-12 |
2023-04-20 |
Cartesian Therapeutics, Inc. |
Viral vector dosing protocols
|
WO2023064367A1
(en)
|
2021-10-12 |
2023-04-20 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector igm responses
|
WO2023086615A1
(en)
|
2021-11-14 |
2023-05-19 |
Selecta Biosciences, Inc. |
Multiple dosing with viral vectors
|
US20230263906A1
(en)
|
2022-01-10 |
2023-08-24 |
Selecta Biosciences, Inc. |
High affinity il-2 receptor agonists and synthetic nanocarrier dose sparing
|
WO2023172624A1
(en)
|
2022-03-09 |
2023-09-14 |
Selecta Biosciences, Inc. |
Immunosuppressants in combination with anti-igm agents and related dosing
|
US20230322884A1
(en)
|
2022-03-09 |
2023-10-12 |
Selecta Biosciences, Inc. |
Immunosuppressant in combination with high affinity il-2 receptor agonists and related dosing
|
US20230372535A1
(en)
|
2022-03-25 |
2023-11-23 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers comprising an immunosuppressant in combination with high affinity il-2 receptor agonists and anti-igm agents
|
US20230381277A1
(en)
|
2022-04-08 |
2023-11-30 |
Selecta Biosciences, Inc. |
High affinity il-2 receptor agonists and immunosuppressants to enhance immune tolerance
|